Characterization of a rare mosaic unbalanced translocation of t(3;12) in a patient with neurodevelopmental disorders.
Hu, X; Baker, EK; Johnson, J; Balow, S; Pena, LD M; Conlin, LK; Guan, Q; Smolarek, TA.
Molecular Cytogenetics.
2022;
15.
Genetic Testing in Patients with Neurodevelopmental Disorders: Experience of 511 Patients at Cincinnati Children's Hospital Medical Center.
Du, X; Glass, JE; Balow, S; Dyer, LM; Rathbun, PA; Guan, Q; Liu, J; Wu, Y; Dawson, DB; Walters-Sen, L; et al.
Journal of Autism and Developmental Disorders.
2022;
52:4828-4842.
Trisomy 9 mosaic syndrome: Sixteen additional patients with new and/or less commonly reported features, literature review, and suggested clinical guidelines.
Li, M; Glass, J; Du, X; Dubbs, H; Harr, MH; Falk, M; Smolarek, T; Hopkin, RJ; Zackai, E; Sheppard, SE.
American Journal of Medical Genetics, Part A.
2021;
185:2374-2383.
Characterizing temporal genomic heterogeneity in pediatric low-grade gliomas.
Lazow, MA; Hoffman, L; Schafer, A; Osorio, DS; Boué, DR; Rush, S; Wright, E; Lane, A; DeWire-Schottmiller, MD; Smolarek, T; et al.
Acta neuropathologica communications.
2020;
8.
Aneuploid embryo transfer: clinical policies and provider opinions at United States fertility clinics.
McGowan, R; Pilipenko, V; Smolarek, TA; West, E; Tolusso, LK.
Fertility and Sterility.
2020;
114:110-117.
Confirmatory testing illustrates additional risks for structural sex chromosome abnormalities in fetuses with a non-invasive prenatal screen positive for monosomy X.
Sund, KL; Khattar, D; Boomer, T; Caldwell, S; Dyer, L; Hopkin, RJ; Smolarek, TA.
American Journal of Medical Genetics, Part C: Seminars in Medical Genetics.
2020;
184:294-301.
Evidence-based review of genomic aberrations in B-lymphoblastic leukemia/lymphoma: Report from the cancer genomics consortium working group for lymphoblastic leukemia.
Akkari, YM N; Bruyere, H; Hagelstrom, RT; Kanagal-Shamanna, R; Liu, J; Luo, M; Mikhail, FM; Pitel, BA; Raca, G; Shago, M; et al.
Cancer genetics.
2020;
243:52-72.
Algorithm-Driven Electronic Health Record Notification Enhances the Detection of Turner Syndrome.
Alexandrou, E; Cabrera-Salcedo, C; Labilloy, G; Tyzinski, L; Smolarek, TA; Andrew, M; Huang, Y; Backeljauw, P; Dauber, A.
(2020)
216:227-231.
The Value of Chromosome Analysis to Interrogate Variants in DNMT3B Causing Immunodeficiency, Centromeric Instability, and Facial Anomaly Syndrome Type I (ICF1).
Kellner, ES; Rathbun, PA; Marshall, GS; Tolusso, LK; Smolarek, TA; Sun, M; Chandra, S; Bleesing, J; Marsh, RA.
Journal of Clinical Immunology.
2019;
39:857-859.
6. Expansion of the validation of Illumina MethylationEPIC BeadChip for medulloblastoma (MB) subgrouping and copy number analysis across institutions and results from the initial 47 clinical cases.
Smolarek, T; Hott, B; Salloum, R; Fuller, C; Ramaswamy, V; Taylor, M; Fouladi, M; Dyer, L; Drissi, R.
Cancer genetics.
2019;
233.